Cargando…
Targeted genetic testing for familial hypercholesterolaemia using next generation sequencing: a population-based study
BACKGROUND: Familial hypercholesterolaemia (FH) is a common Mendelian condition which, untreated, results in premature coronary heart disease. An estimated 88% of FH cases are undiagnosed in the UK. We previously validated a method for FH mutation detection in a lipid clinic population using next ge...
Autores principales: | Norsworthy, Penny J, Vandrovcova, Jana, Thomas, Ellen RA, Campbell, Archie, Kerr, Shona M, Biggs, Jennifer, Game, Laurence, Soutar, Anne K, Smith, Blair H, Dominiczak, Anna F, Porteous, David J, Morris, Andrew D, Scotland, Generation, Aitman, Timothy J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083361/ https://www.ncbi.nlm.nih.gov/pubmed/24956927 http://dx.doi.org/10.1186/1471-2350-15-70 |
Ejemplares similares
-
Identification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia
por: Thomas, Ellen R A, et al.
Publicado: (2013) -
Differential effects of the APOE e4 allele on different domains of cognitive ability across the life-course
por: Marioni, Riccardo E, et al.
Publicado: (2016) -
Pedigree and genotyping quality analyses of over 10,000 DNA samples from the Generation Scotland: Scottish Family Health Study
por: Kerr, Shona M, et al.
Publicado: (2013) -
Hypercholesterolaemia: optimal treatment by next-generation drugs?
por: van der Wall, E.E.
Publicado: (2015) -
Performance evaluation of Sanger sequencing for the diagnosis of primary hyperoxaluria and comparison with targeted next generation sequencing
por: Williams, Emma L, et al.
Publicado: (2015)